Frequency of minimal residual disease as measured by ctDNA in mismatch repair deficient tumors following curative resection.

e14520Background: Mismatch repair deficient (MMRd) tumors are highly sensitive to checkpoint blockade (CPB) in patients with metastatic disease regardless of tumor type. However, the efficacy of CP...